The effects of packaging on the stability of a moisture sensitive compound

被引:43
作者
Allinson, JG
Dansereau, RJ
Sakr, A
机构
[1] Univ Cincinnati, Coll Pharm, Cincinnati, OH 45267 USA
[2] Procter & Gamble Pharmaceut, Mason, OH 45040 USA
关键词
package; stability; moisture sensitivity; tablet; container's permeation; Fick's law;
D O I
10.1016/S0378-5173(01)00670-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Packages that provided stability (less than a 10% loss in potency) of a moisture sensitive compound (PGE-7762928) in tablet form at accelerated conditions for 6 months were identified. The equilibrium moisture content of the tablets at 25 degreesC/60%RH, 30 degreesC/60%RH and 40 degreesC/75%RH were 2.3, 2.4, and 2.9% respectively. The tablet equilibrium moisture content, degradation rate of unpackaged product, and the moisture barrier properties of the packages were used to predict the stability of the packaged product. The physical and chemical stability (HPLC assay) of the products were measured after 2, 4, 6, 8, 12, and 24 weeks at ICH conditions. The Containers-Permeation(1) of polyvinyl chloride blisters, cyclic olefin blisters, aclar blisters, cold-form aluminum blisters was 0.259, 0.040, 0.008 and 0.001 mg per blister per day, respectively. At 6 months at 40 degreesC/75%RH, the percent active was 84% in polyvinyl chloride blisters, 91%, in cyclic olefin blisters, 97% in aclar blisters, 100% in cold-form aluminum blisters and 99% in an high density polyethylene bottle with a foil induction seal. The stability results for the packaged product were fairly consistent with the predictions based on the moisture sensitivity of the product and the moisture barrier properties of the respective package. To gain a better prediction, the flux value determined by the Containers-Permeation procedure was adjusted for the internal moisture concentration of the blister. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 16 条
  • [1] ALLEN D, 1999, PHARM MED PACKAG NEW, V7, P45
  • [2] AMIDON GE, 1988, INT J PHARM, V189, P81
  • [3] *ASTM, 1994, 307894 ASTM D
  • [4] BURAT T, 1992, STP PHARMA SCI, V2, P351
  • [5] CANEFE K, 1989, Gazi Universitesi Eczacilik Fakultesi Dergisi, V6, P7
  • [6] CARSTENSEN JT, 1993, PHARMACEUTICAL PRINC, P180
  • [7] Gander P, 1999, MANUF CHEMIST, V70, P31
  • [8] GAZDA M, 1998, PGE7762928
  • [9] HUNT N, 1999, PHARM MED PACKAG NEW, V7, P36
  • [10] *ICH STEER COMM, 1994, STAB TEST NEW DRUG S